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ABSTRACT 
Recombinant measles viruses are currently tested in clinical trials as oncolytic agent to be applied in cancer 
therapy. Contrary to their use as vaccine where 103 infectious virus particles per dose are needed, for cancer 
therapy 109 virus particles should be provided per dose. This leads to other challenges for the production 
process when compared to vaccine production. This study presents measles virus stability with regard to 
conditions during production and storage of the virus. Relevant process parameters such as temperature (4-
37°C), pH (pH 4-11), conductivity (1.5 to 137.5 mS cm−1) and oxygen partial pressure were analyzed. The 
infectivity of measles virus particles decreased highly at 37 and 32°C, while at 22 and 4°C it remained stable 
for several hours or even days, respectively. The thermal inactivation reactions followed first order kinetics 
and the thermodynamic parameters enthalpy and entropy were estimated. Towards changes in pH measles 
virus particles were very sensitive, while no inactivation could be observed with varying conductivity. 
Measles virus incubation at an oxygen partial pressure of 100% did not lead to any loss of infectivity. The 
results show which parameters should be considered and controlled strongly in the production process to 
further raise measles virus yields for the high amount needed in cancer therapy approaches. 
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1. INTRODUCTION 
As a member of the order Mononegavirales (family: 
Paramyxoviridae), Measles Virus (MV) is an RNA virus 
with a single stranded genome in negative-sense orientation. 
The genome is wrapped in a Ribonucleoprotein (RNP) 
complex and enveloped by a lipid layer containing the viral 
glycoproteins hemagglutinin and fusion protein 
(Navaratnarajah et al., 2009). The virus particles have a size 
of 120-270 nm. MV is the causative agent of the disease 
measles, which is highly infectious and characterized by 
the so called Koplik spots, high fever and a weakened 
immune system. Although the course of disease is often 
relatively mild, life-threatening complications such as 
Subacute Sclerosing Panencephalitis (SSPE) appear with 
relative low frequency, but regularly (Sabella, 2010). 
These complications can be prevented by vaccination 
with attenuated MV vaccine strains which have been 
used in several millions of doses and have revealed an 
excellent safety profile.  
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MV induces a Cytophatic Effect (CPE), i.e., cell-
to-cell fusion and the formation of multi-nucleated 
giant cells, ultimately leading to induction of 
apoptosis and killing of infected cells. Current studies 
in cancer therapy try to take benefit of this inherent 
cytotoxicity, as derivatives of an MV vaccine strain 
are currently tested in clinical trials for cancer therapy 
(Msaouel et al., 2012). The ability of MV to kill 
cancer cells has been correlated to cell entry of 
attenuated MV via CD46; this receptor is frequently 
over-expressed on tumor cells (Anderson et al., 2004). 
Preclinical, unmodified and recombinant MV strains 
have revealed oncolytic potency in numerous models 
including xenograft tumor models of human lymphoma 
(Grote et al., 2001), ovarian cancer (Peng et al., 2002), 
or prostate cancer (Msaouel et al., 2009). 
The infectivity of MV particles is the basic 
requirement for the success of oncolytic virotherapy. 
Moreover, the amount of virus particles for one 
therapeutic dose is up to 3 to 6 log10 units higher than 
those traditionally used for vaccination (Msaouel et al., 
2012; Russel et al., 2010). For these reasons, stability 
studies of MV under production conditions (especially 
medium, oxygen saturation, ion strength, pH and 
temperature) are important to retain the infectivity 
during upstream and downstream processing. This will 
be essential for generation of the required doses of 
infectious virus particles.  
Virus inactivation in general was reported to 
proceed similar to cell dying (Bauer and Henle, 1979; 
Johnson, 1974) or protein and enzyme inactivation 
(Weemaes et al., 1997; 1998). All reports about MV 
stability in general have been published decades ago. 
Temperature (Black, 1959; Boriskin et al., 1988; 
Musser et al., 1960; Rapp et al., 1965), pH (Black, 
1959; Musser et al., 1960) and salt concentrations 
(Boriskin et al., 1988; Rapp et al., 1965) were the 
most important factors analyzed, then. Recently, some 
work has focused on stability studies for MV vaccines 
after production and purification (Burger et al., 2008; 
Ohtake et al., 2010). While these virus particles are 
stabilized with different agents or are even 
lyophilized, this stability studies are not representative 
for measles virus particles under production 
conditions. The key parameters for MV production for 
the use in cancer therapy were already discussed in a 
previous review (Weiss et al., 2012). 
The current study aims to target MV stability of 
MV-batches for high-dose applications such as 
virotherapy. For process parameters during production 
and purification the presented data involve 
determination of temperature inactivation constants, 
analysis of the impact of pH, pO2, or certain salts. The 
determined parameters may serve as a basis for 
optimizing MV production and purification in future 
applications such as oncolytic virotherapy requiring 
comparatively high doses of infectious virus. 
2. MATERIALS AND METHODS 
2.1. Cells and Virus 
Infectious recombinant MV particles of the strain 
MVvac2 GFP (P) were rescued and propagated as 
described previously (Devaux et al., 2007). MV was 
propagated in Vero cells (# CCL-81, ATCC) under 
standard culture conditions. Titers were determined 
according to (Karber, 1931; Reed and Muench, 1938). 
Cells were adapted to grow in serum free VPSFM 
medium (Gibco, Invitrogen) supplemented with 4 mM 
glutamine (PAA, Germany) over 5 passages and were 
expanded in T flasks at 37°C and 5% CO2, without any 
substituents of animal origin. Infections were 
performed at a cell density of 50.000 cells cm−2 with an 
MOI of 0.02. Measles virus suspensions were collected 
from the supernatant after centrifugation (5 min, 300 g 
(Megafuge 1.0R, Thermo Scientific)). 
2.2. Temperature Stability Studies  
MV suspension were incubated at 4, 22, 32, or 
37°C in the dark for the indicated time. After exposure 
at 4°C, residual virus titers were always determined 
immediately after sampling. After exposure at 22°C, 
32°C or 37°C samples were first frozen at-20°C in a 
radiator block to immediately stop particle decay 
before titrating residual titers. 
2.3. pH Stability Studies 
MV particle suspensions were supplemented with 
appropriate volumes of 1 M NaOH or 1 M HCl to 
adjust the pH to the desired range. The virus solutions 
at pH 5, 6, 7, 8, 9 and 10 were titrated according to the 
TCID50 method immediately after adjustment of pH 
and after 3 h incubation (at 4°C, in the dark), 
respectively. 
2.4. Salt Stability Studies 
MV suspensions were incubated with different salt 
solution at different concentrations. MgSO4 and NaCl 
solutions at 1.5 M, 1 M, 0.5 M, 0.25 M and 0.1 M 
were analyzed. For this purpose, appropriate volumes 
of 3 M stock solution of each salt were given to 
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different aliquots of same virus suspensions to adjust 
salt concentrations. TCID50 titration of residual 
infectivity was done immediately after salt 
supplementation and after 3 h of incubation. 
Conductivity measurements of adjusted suspensions 
were performed using the SevenGoDuoPro device 
from Mettler Toledo. 
2.5. pO2 Stability Studies 
For the analysis of pO2 stability, MV suspensions were 
diluted in ice cold phosphate buffer saline at pH 7.2. 
Conditions were chosen as currently tested for measles 
virus production (manuscript in preparation), using impeller 
stirrer in 1 L Stirred Tank Reactor (STR). 
3. RESULTS 
3.1. Measles Virus Thermal Inactivation 
To investigate the MV inactivation rates at 
different temperatures, measles virus suspensions 
were incubated at 37°C, 32°C (potential temperatures 
for production), 22°C (room temperature), or 4°C 
(storing temperature) and virus titer were determined 
after defined time spans. 
Figure 1 shows an increase of MV inactivation rates 
with increasing temperature. At 37°C and 32°C MV 
half-life were one and two hours respectively. When 
starting with a titer of 6.3×105 TCID50/mL, the MV 
titer was below the limit of detection (102 TCID50/mL) 
after an incubation of 23 h at 37°C. At 22°C and 4°C, 
MV was more stable indicated by higher half-life 
times (18 h and 5 d, respectively). 
In Fig. 1 MV inactivation is displayed 
semilogarithmic. An exponential regression was fitted to 
the data sets. The exponent of the respective regression 
lines gives the inactivation rate constant k. According to 
Arrhenius (Equation 1) the estimated k-values (lnk) against 
temperature (T−1) resulted in a linear correlation (Fig. 2), 
where the slope represents the term EA R−1. Taking 
Equation 2-4 the thermodynamic parameters enthalpy and 
entropy can be estimated (Johnson, 1974): 
 
AE
R Tk A e ⋅= ⋅  (1) 
 
Where: 
A = The pre-exponential factor (h−1) 
EA = The activation energy (kJ mol−1) 
R = The universal gas constant (kJ mol−1 K−1) 
T = The temperature (K) 
G
B R Tk Tk e
h
−∆
⋅
⋅
= ⋅  (2) 
 
Eyring Equation, where: 
kB = The Boltzmann constant (kJ K−1) 
h = The Planck’s constant (J s) 
∆G = Gibbs energy (kJ mol−1) 
 
A∆H= E - R.T  (3) 
 
∆H is the enthalpy of activation (kJ mol−1): 
 
1S ( H G) T−∆ = ∆ − ∆ ⋅
 (4) 
 
∆S is the entropy of activation (kJ mol−1 K−1). 
The estimated thermodynamic parameters for MV 
inactivation are presented in Table 1. The enthalpy for 
measlesvirus inactivation was 104 kJ mol−1 (25 kcal 
mol−1) and the entropy had a value of 0.08 kJ mol−1 (0.02 
kcal mol−1). 
3.2. Measles Virus pH Stability 
To estimate MV stability at various pH values, MV 
titers were determined at pH values between 4 and 11 
(Fig. 3). 
Directly after pH adjustment, the MV titer 
decreased below the limit of detection at pH 4 and pH 
11. Therefore MV was referred to be completely 
inactivatedunder these conditions. In the acid pH 
range no infectious MV particles were found (pH 5) 
immediately after adjustment or a decrease of approx. 
2 orders of magnitude appeared (pH 6). In the basic 
pH range, directly after pH adjustment to pH 8, 9, or 
10, MV titers decreased by approx. one order of 
magnitude (1.1 to 1.6 log10 units). After 3h incubation 
time at acidic and basic pH MV titers were close to 
the detection limit in all approaches. 
The highest titer was estimated at pH 7. Interestingly, 
only small changes in pH from 7.2 to 7.0 resulted in a 
titer decrease of one order of magnitude after 3h of 
incubation, highlighting the sensitivity of MV particles 
against pH changes. 
3.3. Measles Virus Stability at Different Salt 
Concentrations 
To estimate whether MV inactivation at various pH 
values away from neutral pH was due to increased salt 
concentrations, MV infectivity was analyzed at different 
salt concentrations and conductivities. 
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Fig. 1. Thermal inactivation of MV at 37°C, 32°C, 22°C and 4°C. Incubation studies were performed in triplicate, except for the 
temperature at 22°C. The virus titers are given as relative values divided by virus titer at time point zero of incubation. Lines 
represent exponential regression of respective data sets. Error bars indicate standard deviation. 
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Fig. 2. Arrhenius plot for measles virus thermal inactivation. Values for inactivation constant k were estimated by exponential 
regression of data sets from Fig. 1. 
 
 
 
Fig. 3. Inactivation of MV at different pH. For pH adjustment of MV suspensions, respective volumes of 1 M NaOH and 1 M 
HCl were added. Virus titers were determined directly after pH adjustment (black bars) or after 3 h incubation in the 
dark at 4°C (hatched bars). 
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Fig. 4. Oxygen stability of MV particles. Measles virus suspension was stirred in an STR at 70 rpm, pH 7.2, 0.1% (w/v) Pluronic 
F68 and 100% pO2; samples were taken at the indicated time points and subsequently titrated. The horizontal line at 1x104 
TCID50/mL is displayed for easier comparability of different values. 
 
Table  1. Estimated thermodynamic coefficients for measles virus thermal inactivation 
∆H/kJ mol−1 ∆S/kJ mol−1 K−1 ∆G/kJ mol−1 
104 0.08 78 
∆H/kcal mol−1 ∆S/kcal mol−1 K−1 ∆G/kcal mol−1 
25 0.02 19 
 
Table 2. Measles virus stability at different conductivities in diluted water and in NaCl and MgSO4 salt solutions 
  Log10 TCID50 mL−1 
  ------------------------------------------------------------------------------ 
Sample name Conductivity/mS cm−1 Directly After 3 h incubation 
Reference 013.28 6.10±0.17 6.47±0.23 
1.5M NaCl 137.50 6.19±0.42 6.60±0.44 
1M NaCl 094.30 6.21±0.15 6.31±0.55 
0.5M NaCl 054.70 6.07±0.06 6.46±0.53 
0.25M NaCl 037.80 5.92±0.30 6.39±0.69 
0.1M NaCl 023.99 5.83±0.11 6.66±0.43 
1.5M MgSO4 059.80 5.96±0.47 6.05±0.27 
1M MgSO4 052.90 6.13±0.43 6.62±0.35 
0.5M MgSO4 040.10 6.18±0.35 6.26±0.28 
0.25M MgSO4 032.10 6.57±0.23 6.18±0.54 
0.1M MgSO4 030.42 6.98±0.43 6.06±0.11 
Dilution factor (aquadest): 
2 006.71 6.37±0.26 6.12±0.51 
5 002.78 6.39±0.19 6.01±0.19 
10 001.49 6.15±0.13 5.77±.0.25
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 In Table 2, virus titers determined at different 
conductivities and salt concentrations are displayed. 
Neither measles virus suspensions with NaCl, or MgSO4 
at 0.1 to 1.5 M, respectively, nor up to 10-fold dilutions 
with distilled water resulted in significant virus titer 
decrease. Therefore, measles virus was observed to be 
very stable at conductivities between 1.5 to 137.5 mS 
cm−1. Thus, a decrease of virus titer under different pH 
conditions can be addressed to different proton 
concentrations, not salt ions or conductivities. 
3.4. Measles Virus Oxygen Stability 
As MV is produced by an aerobically host cell, 
oxygen supply and sensitivity might play an important 
role for MV production. For this reason an exemplary 
analysis was done to estimate MV stability under 
production conditions. Measles virus suspension was 
stirred in STR at pH 7.2, 70 rpm, 8°C and 100% pO2. 
Within 6 h, the virus titer did not vary to a significant 
level, so no inactivation has been observed due to high 
oxygen partial pressure. Under the above described 
conditions, oxygen concentration according to MV particles 
inactivation is not a critical factor for MV production. 
4. DISCUSSION 
For the application of measles virus in cancer therapy 
up to 1,000,000 more infectious virus particles are 
needed compared to vaccination (Russel et al., 2010). 
For this reason, first, an effective oncolytic measles virus 
production process should be established or the measles 
virus has to be highly concentrated with preserved 
infectivity to get these high titers. Second, since a 
successful therapy will be dependent on the infectivity of 
the virus particles, measles virus stability is an important 
issue and has to be integrated into MV production 
considerations. In this study stability studies of infectious 
MV suspensions in serum free medium are presented 
aiming to analyze the impact of conditions like pH or 
temperature that play an important role during production 
of MV in upstream and downstream processing. Finally, 
critical parameters were identified to further raise MV 
yields for the relative high amount needed e.g., for cancer 
therapy approaches (Russel et al., 2010).  
The parameter temperature is a very important 
factor, as temperatures around 30°C are minimally 
required for the host cell maintenance metabolism and 
even for virus production. Contrary MV (Edmonston 
strain) has been reported to be very sensitive towards 
temperatures above 30°C, (Black, 1959; Kohn and 
Yassky, 1962; Musser et al., 1960; Rapp et al., 1965). 
A half-life of two hours was determined at 37°C for the 
Edmonston strain, according to about 100 % loss within 
4 h (Black, 1959), while a decrease in virus titer of 90 % 
within 16 h was reported by (Kohn and Yassky, 1962) 
and within 13 h by (Musser et al., 1960). The AIK-C 
MV strain at 28°C incubation was completely inactivated 
within 3 days (a loss of over 7 orders of magnitudes) and 
at 4°C the virus titer decreased about 2 log10 units within 
10 days and remained after that stable for another 2 days 
(Trabelsi et al., 2012). The Edmonston strain lost its 
infectivity at 23°C with a rate of approx. one order of 
magnitudes in 24 h (Black, 1959). In accordance with 
the data presented here, inactivation at 37°C or 32°C 
occurs with a half-life of just 1 or 2 h, respectively, 
where an inactivation at room temperature or at 4°C 
was significantly slower (Fig. 1). 
The medium of the MV suspension seems to be an 
important factor for MV stability at different 
temperatures. The present studies were done in serum 
free VPSFM, as this medium is suitable for MV 
production under serum free conditions (own 
unpublished data). As already mentioned above, the half-
life determined in the current set-up were quite 
comparable to those reported in Eagle’s medium 
supplemented with 10% calf serum (Black, 1959), where 
a half-life of two hours was determined at 37°C. In 
medium 199 without serum, a drop of infectivity of 2.4 
log10 units has been demonstrated after 7 h incubation at 
25°C. At 37°C no virus inactivation could be observed 
(3.2 +/-0.2 log10TCID50 mL−1) but after 24 h a drop of 
two log10 units appeared (Musser et al., 1960). 
Nevertheless, this is the only report about a higher 
stability at a higher temperature for measles virus. This is 
in contrast to the data presented in this study.  
Interestingly, a higher inactivation rate was reported 
at 6°C, when MV particles were prepared in serum free 
medium. At this temperature, MV titers decreased to 
10% of original titers in serum free preparations within 4 
weeks, while in serum containing medium the virus titer 
was more or less stable (5 +/-0.3 log10 TCID50 mL−1) 
(Musser et al., 1960). In water-suspensions, MV 
preparations lost 90% of infectivity within 24 h at 4°C 
and 50% within 1 h at 25°C (Rapp et al., 1965). This 
shows that measles virus particles in suspension need 
certain supplements to retain their infectivity. While 
serum was reported to be very effective, other 
supplements like sugar, amino acids and divalent ions 
were already reported to preserve measles virus 
infectivity (Trabelsi et al., 2012). 
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The thermal inactivation reactions follow first order 
kinetics for all analyzed temperatures (Fig. 1), which is 
also reported for tobacco mosaic virus (Ginoza, 1958), 
Sindbis virus (Barnes et al., 1969) and baculovirus 
(Gotoh et al., 2008). The corresponding Arrhenius plot 
(Fig. 2) indicates only one process parameter that 
contributes to MV inactivation due to temperature 
sensitivity in our experimental setting. A two component 
mode mechanism of inactivation in which inactivation 
proceeds in the first place in a faster manner and then a 
slower degradation is observed that follows first order 
kinetics had been reported for lyophilized measles 
vaccine (Allison et al., 1981; Colinet et al., 1982). For 
unprocessed MV at 45°C and 50°C this so called two 
component mode has also been shown for the Schwarz 
and Mantooth strain (Albrecht and Schumacher, 1972) 
and at 4°C for the AIK-C strain (Trabelsi et al., 2012). 
For the Edmonston MV strain a two component 
inactivation was suggested only by the data at45°C or 
50°C (Rapp et al., 1965).  
In a previous study (Woese, 1960), an enthalpy of 20 
kcal mol−1 and an entropy of -19 cal mol−1 °C−1 had been 
determined for Tobacco Mosaic Virus (TMV) RNA 
which was designated to be associated with RNA 
inactivation. In general RNA inactivation was 
accompanied by a small value for enthalpy and a 
negative value for entropy. In the same study, positive 
entropy values between 3 to 950 cal mol−1 °C−1 of 
thermal inactivation were reported for proteins, bacterial 
and plant viruses and other animal viruses (Woese, 
1960). The thermodynamic parameters for MV 
inactivation as determined in this study are summarized 
in Table 1. The enthalpy and entropy for thermal 
inactivation of MV were 25 kcal mol−1 and 20 cal 
mol−1 K−1, respectively. According to Woese (1960), the 
values in this study could suggest that measles virus 
inactivation is accompanied by both RNA and protein 
inactivation. For the enthalpy of measles virus heat 
inactivation values of 18 to 70 kcal mol−1 (23°C to 56°C) 
were reported in the literature (Woese, 1960). As the 
enthalpy is greater than zero the reaction is so called 
endothermic, which means that for measles virus 
inactivation energy must be absorbed into the system. 
According to the second law of thermodynamic, an 
entropy larger than zero indicates an irreversible 
reaction, meaning that in this study MV thermal 
inactivation is estimated to be a non-reversible process. 
Measles virus thermal inactivation as a reversible 
process, according to entropy of zero, has never been 
reported and such back formation without any permanent 
alteration of the system or its surrounding is not expected 
for a biological system.  
Similar to Murine Leukemia Virus (MLV) production, 
the high degradation rate at 37°C (Nehring et al., 2006) 
presents a new challenge for the production process. To 
achieve the high amounts of infectious virus particels 
virus filtration for concentration is a possible solution, like 
it has been reported for MLV, (Nehring et al., 2004; 
2009), densonucleosis virus (Czermak et al., 2008; 
Grzenia et al., 2006; Specht et al., 2004), recombinant 
baculovirus (Grein et al., 2012; Michalsky et al., 2009; 
2010) and minute virus (Hensgen et al., 2010). MV 
purification in a scale of up to 60 L is already reported 
by Langfield et al. (2011), but especially the half-life of 
2 and 1 h of MV particles at 32 and 37°C, respectively, 
suggests inline filtration with continues harvest and 
immediate cooling like it has already been reported for 
MLV particles (Nehring et al., 2009). 
Referring to pH stability, the data in this report (Fig. 
3) reveal that MV is very sensitive towards changes 
away from neutral (pH 7.2). This shows that process 
conditions have to be adjusted during upstream and 
downstream processing. Inactivation of MV due to pH 
sensitivity has already been presented, before. Similar to 
the results presented here, a total virus inactivation at pH 
>10 or < 5 has been reported (Musser et al., 1960). 
Stable virus titers were identified between pH 7 and 8, 
whereas between pH 5 and 7 or 8 and 9 inactivation was 
between one to two log10 units (Musser et al., 1960). 
Black reported a maximum virus titer of 7.9×103 pfu at 
pH 7.6, a stable titer from pH 6 to 10.5 (maximum 
decrease of 0.6 log10 units), but a comparably high 
inactivation at pH 4.4, 3.8 and 2.4 of 2.8 log10 units, 
representing a loss of 80% (Black, 1959). Such 
sensitivity towards pH changes was also reported for 
recombinant baculovirus. In this case particles 
aggregation due to pH changes has been suggested to 
be responsible for the observed virus inactivation 
(Grein et al., 2012). The data show that for an 
optimized production process pH regulation in narrow 
limits during upstream and downstream processing is 
essential to preserve measles virus infectivity. 
As depicted in Table 2, MV titers did not 
significantly decrease with either a rising or falling 
conductivity. This stability of MV under different salt 
concentrations indicates that the sensitivity of MV to pH 
differing from neutral was not due to enhanced ion 
concentrations, but linked to proton concentration. The 
ions Ca2+, Zn2+ and Mg2+ can be associated to different 
proteins and especially MgSO4 was reported to improve 
MV stability or even production yield (Boriskin et al., 
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1988; Rapp et al., 1965; Trabelsi et al., 2012). While 
a negative impact of MgSO4 on measles virus could 
not be observed in the present study, it possibly 
improves the virus yield during production. 
To date, no analysis concerning the sensitivity of MV 
towards oxygen has been published. However, this 
parameter is essential in bioprocess evaluation and scale 
up investigations as it is necessary for the growth of the 
mammalian host cells. Especially in scale up 
investigations dealing with high cell concentrations 
aeration and the oxygen partial pressure is an important 
factor. The negative effect of oxygen is given by the 
formation of oxygen radicals in redox reactions by 
several enzymes. Oxygen radicals are highly reactive and 
contingently destructive to biomolecules or its functional 
groups. Therefore, high oxygen concentrations 
potentially resulting in generation of larger amounts of 
oxygen radicals may be counterproductive for virus 
stability due to biochemical redox reactions e.g., with 
subsequent inactivation of viral surface proteins critical 
for infectivity (Lim et al., 1999). For these reasons it was 
analyzed, whether oxygen is a critical parameter for MV 
stability. For an exemplary test, small scale laboratory 
conditions were chosen, where measles virus production 
is currently evaluated (manuscript in preparation). Under 
these conditions MV titers were stable at an oxygen 
partial pressure of 100%, indicating resistance of MV 
particles against inactivation under high oxygen 
concentrations. The result presented shows that in scale 
up investigations a high oxygen demand of Vero cell 
cultures after infection is no critical factor after infection, 
whereby this enables working at high cell concentrations. 
In summary, this study shows which parameters 
should be considered for further production 
evaluation. Identified critical parameters could be 
controlled strongly in the production process to 
further raise measles virus yields for the high amount 
needed in cancer therapy approaches. High thermal 
inactivation should be considered when thinking about 
time of harvest or continuous cooling during 
downstream processing. A half-life of 1 and 2h at 37 
and 32°C, respectively, shows that harvest of measles 
virus particles should be performed several fold or 
even continuously. After that immediate cooling of 
the virus suspension is essential to retain the 
infectivity. pH sensitivity is also an important factor 
when thinking about automatic pH regulation during 
measles virus production. Interestingly, measles virus 
showed no sensitivity towards an oxygen partial 
pressure of 100% or varying conductivities between 
1.4 and 138 mS cm−1. Measles virus stability towards 
different salt concentrations could be an advantage in 
purification approaches using ion exchange membrane 
chromatography. This purification has already been 
reported for recombinant baculovirus (Grein et al., 
2012) and densonucleosis virus (Specht et al., 2004). 
5. CONCLUSION 
The results presented show how process 
parameters could affect final infectious MV yields at 
production and purification. 
Aiming for high amounts of infectious MV particles 
for the applications in cancer therapy, future studies 
should go in more detailed investigations for MV 
stability and should also integrate them into the 
evaluation of MV production. 
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